Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states
Pablo Perez-Martinez, Dolores Corella, Jian Shen, Donna K Arnett, Nikos Yiannakouris, E Syong Tai, Marju Orho-Melander, Katherine L Tucker, Michael Tsai, Robert J Straka, Michael Province, Chew Suok Kai, Francisco Perez-Jimenez, Chao-Qiang Lai, Jose Lopez-Miranda, Marisa Guillen, Laurence D Parnell, Ingrid Borecki, Sekar Kathiresan, Jose M Ordovas, Pablo Perez-Martinez, Dolores Corella, Jian Shen, Donna K Arnett, Nikos Yiannakouris, E Syong Tai, Marju Orho-Melander, Katherine L Tucker, Michael Tsai, Robert J Straka, Michael Province, Chew Suok Kai, Francisco Perez-Jimenez, Chao-Qiang Lai, Jose Lopez-Miranda, Marisa Guillen, Laurence D Parnell, Ingrid Borecki, Sekar Kathiresan, Jose M Ordovas
Abstract
Background: Hypertriglyceridemia is a risk factor for cardiovascular disease. Variation in the apolipoprotein A5 (APOA5) and glucokinase regulatory protein (GCKR) genes has been associated with fasting plasma triacylglycerol.
Objective: We investigated the combined effects of the GCKR rs780094C-->T, APOA5 -1131T-->C, and APOA5 56C-->G single nucleotide polymorphisms (SNPs) on fasting triacylglycerol in several independent populations and the response to a high-fat meal and fenofibrate interventions.
Design: We used a cross-sectional design to investigate the association with fasting triacylglycerol in 8 populations from America, Asia, and Europe (n = 7,730 men and women) and 2 intervention studies in US whites (n = 1,061) to examine postprandial triacylglycerol after a high-fat meal and the response to fenofibrate. We defined 3 combined genotype groups: 1) protective (homozygous for the wild-type allele for all 3 SNPs); 2) intermediate (any mixed genotype not included in groups 1 and 3); and 3) risk (carriers of the variant alleles at both genes).
Results: Subjects within the risk group had significantly higher fasting triacylglycerol and a higher prevalence of hypertriglyceridemia than did subjects in the protective group across all populations. Moreover, subjects in the risk group had a greater postprandial triacylglycerol response to a high-fat meal and greater fenofibrate-induced reduction of fasting triacylglycerol than did the other groups, especially among persons with hypertriglyceridemia. Subjects with the intermediate genotype had intermediate values (P for trend <0.001).
Conclusions: SNPs in GCKR and APOA5 have an additive effect on both fasting and postprandial triacylglycerol and contribute to the interindividual variability in response to fenofibrate treatment.
Figures
Source: PubMed